Cargando…
Clinical Characteristics of Korean Breast Cancer Patients Who Carry Pathogenic Germline Mutations in Both BRCA1 and BRCA2: A Single-Center Experience
There are few reports of breast cancer patients who carry germline mutations in both germline breast cancer susceptibility genes 1 (gBRCA1) and 2 (gBRCA2). In this study, we analyzed the clinical, pathological, and genomic characteristics of Korean breast cancer patients with both gBRCA1 and gBRCA2...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281087/ https://www.ncbi.nlm.nih.gov/pubmed/32455662 http://dx.doi.org/10.3390/cancers12051306 |
_version_ | 1783543840419872768 |
---|---|
author | Hur, Joon Young Kim, Ji-Yeon Ahn, Jin Seok Im, Young-Hyuck Lee, Jiyun Kwon, Minsuk Park, Yeon Hee |
author_facet | Hur, Joon Young Kim, Ji-Yeon Ahn, Jin Seok Im, Young-Hyuck Lee, Jiyun Kwon, Minsuk Park, Yeon Hee |
author_sort | Hur, Joon Young |
collection | PubMed |
description | There are few reports of breast cancer patients who carry germline mutations in both germline breast cancer susceptibility genes 1 (gBRCA1) and 2 (gBRCA2). In this study, we analyzed the clinical, pathological, and genomic characteristics of Korean breast cancer patients with both gBRCA1 and gBRCA2 mutations. Medical records of patients who received gBRCA1 and gBRCA2 testing at Samsung Medical Center between January 2007 to October 2018 were retrospectively reviewed. Genomic DNA was isolated from peripheral blood leukocytes. Among a total of 2720 patients, four patients with both gBRCA1 and gBRCA2 mutations were identified (4/2720; 0.14%). Seven patients who had a gBRCA1 mutation and gBRCA2 variants of uncertain significance (VUS) were also identified. In those patients with both gBRCA1 and gBRCA2 mutations, the mean age at diagnosis for breast cancer was 36 years (range, 31–43 years). All four tumors were infiltrating ductal carcinomas and three of the tumors were estrogen receptor-negative, progesterone receptor-negative, and human epidermal growth factor receptor 2-negative (triple-negative). All four patients who carried germline mutations in both BRCA1 and BRCA2 had a family history of breast/ovarian cancer. Pathologic stage was II in three patients and I in one patient. Breast cancer patients with both gBRCA1 and gBRCA2 mutations were rare, young at diagnosis, and all but one tumor was triple-negative based on our single-center experience. |
format | Online Article Text |
id | pubmed-7281087 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-72810872020-06-15 Clinical Characteristics of Korean Breast Cancer Patients Who Carry Pathogenic Germline Mutations in Both BRCA1 and BRCA2: A Single-Center Experience Hur, Joon Young Kim, Ji-Yeon Ahn, Jin Seok Im, Young-Hyuck Lee, Jiyun Kwon, Minsuk Park, Yeon Hee Cancers (Basel) Article There are few reports of breast cancer patients who carry germline mutations in both germline breast cancer susceptibility genes 1 (gBRCA1) and 2 (gBRCA2). In this study, we analyzed the clinical, pathological, and genomic characteristics of Korean breast cancer patients with both gBRCA1 and gBRCA2 mutations. Medical records of patients who received gBRCA1 and gBRCA2 testing at Samsung Medical Center between January 2007 to October 2018 were retrospectively reviewed. Genomic DNA was isolated from peripheral blood leukocytes. Among a total of 2720 patients, four patients with both gBRCA1 and gBRCA2 mutations were identified (4/2720; 0.14%). Seven patients who had a gBRCA1 mutation and gBRCA2 variants of uncertain significance (VUS) were also identified. In those patients with both gBRCA1 and gBRCA2 mutations, the mean age at diagnosis for breast cancer was 36 years (range, 31–43 years). All four tumors were infiltrating ductal carcinomas and three of the tumors were estrogen receptor-negative, progesterone receptor-negative, and human epidermal growth factor receptor 2-negative (triple-negative). All four patients who carried germline mutations in both BRCA1 and BRCA2 had a family history of breast/ovarian cancer. Pathologic stage was II in three patients and I in one patient. Breast cancer patients with both gBRCA1 and gBRCA2 mutations were rare, young at diagnosis, and all but one tumor was triple-negative based on our single-center experience. MDPI 2020-05-21 /pmc/articles/PMC7281087/ /pubmed/32455662 http://dx.doi.org/10.3390/cancers12051306 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Hur, Joon Young Kim, Ji-Yeon Ahn, Jin Seok Im, Young-Hyuck Lee, Jiyun Kwon, Minsuk Park, Yeon Hee Clinical Characteristics of Korean Breast Cancer Patients Who Carry Pathogenic Germline Mutations in Both BRCA1 and BRCA2: A Single-Center Experience |
title | Clinical Characteristics of Korean Breast Cancer Patients Who Carry Pathogenic Germline Mutations in Both BRCA1 and BRCA2: A Single-Center Experience |
title_full | Clinical Characteristics of Korean Breast Cancer Patients Who Carry Pathogenic Germline Mutations in Both BRCA1 and BRCA2: A Single-Center Experience |
title_fullStr | Clinical Characteristics of Korean Breast Cancer Patients Who Carry Pathogenic Germline Mutations in Both BRCA1 and BRCA2: A Single-Center Experience |
title_full_unstemmed | Clinical Characteristics of Korean Breast Cancer Patients Who Carry Pathogenic Germline Mutations in Both BRCA1 and BRCA2: A Single-Center Experience |
title_short | Clinical Characteristics of Korean Breast Cancer Patients Who Carry Pathogenic Germline Mutations in Both BRCA1 and BRCA2: A Single-Center Experience |
title_sort | clinical characteristics of korean breast cancer patients who carry pathogenic germline mutations in both brca1 and brca2: a single-center experience |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281087/ https://www.ncbi.nlm.nih.gov/pubmed/32455662 http://dx.doi.org/10.3390/cancers12051306 |
work_keys_str_mv | AT hurjoonyoung clinicalcharacteristicsofkoreanbreastcancerpatientswhocarrypathogenicgermlinemutationsinbothbrca1andbrca2asinglecenterexperience AT kimjiyeon clinicalcharacteristicsofkoreanbreastcancerpatientswhocarrypathogenicgermlinemutationsinbothbrca1andbrca2asinglecenterexperience AT ahnjinseok clinicalcharacteristicsofkoreanbreastcancerpatientswhocarrypathogenicgermlinemutationsinbothbrca1andbrca2asinglecenterexperience AT imyounghyuck clinicalcharacteristicsofkoreanbreastcancerpatientswhocarrypathogenicgermlinemutationsinbothbrca1andbrca2asinglecenterexperience AT leejiyun clinicalcharacteristicsofkoreanbreastcancerpatientswhocarrypathogenicgermlinemutationsinbothbrca1andbrca2asinglecenterexperience AT kwonminsuk clinicalcharacteristicsofkoreanbreastcancerpatientswhocarrypathogenicgermlinemutationsinbothbrca1andbrca2asinglecenterexperience AT parkyeonhee clinicalcharacteristicsofkoreanbreastcancerpatientswhocarrypathogenicgermlinemutationsinbothbrca1andbrca2asinglecenterexperience |